Tealwood Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.6M | Sell |
|
|||||
|
2025
Q2 | $1.47M | Sell |
|
|||||
|
2025
Q1 | $1.3M | Sell |
|
|||||
|
2024
Q4 | $1.63M | Buy |
|
|||||
|
2024
Q3 | $1.36M | Sell |
|
|||||
|
2024
Q2 | $1.64M | Sell |
|
|||||
|
2024
Q1 | $1.66M | Sell |
|
|||||
|
2023
Q4 | $1.61M | Sell |
|
|||||
|
2023
Q3 | $1.4M | Sell |
|
|||||
|
2023
Q2 | $1.21M | Sell |
|
|||||
|
2023
Q1 | $1.32M | Buy |
|
|||||
|
2022
Q4 | $1.56M | Sell |
|
|||||
|
2022
Q3 | $1.5M | Sell |
|
|||||
|
2022
Q2 | $1.38M | Sell |
|
|||||
|
2022
Q1 | $1.37M | Buy |
|
|||||
|
2021
Q4 | $443K | Sell |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q1 | $1.25M | Buy |
|
|||||
|
2020
Q4 | $1.17M | Buy |
|
|||||
|
2020
Q3 | $579K | Buy |
|